financetom
Business
financetom
/
Business
/
Veeva Systems, Amgen Collaborate to Further Streamline Clinical Trials
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Veeva Systems, Amgen Collaborate to Further Streamline Clinical Trials
Aug 28, 2025 5:29 AM

08:09 AM EDT, 08/28/2025 (MT Newswires) -- Veeva Systems ( VEEV ) said Thursday that has entered into a collaboration with Amgen ( AMGN ) to help the US drugmaker further advance clinical development.

Veeva ( VEEV ) said Amgen ( AMGN ) will use the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process.

Financial terms of the collaboration were not disclosed.

Shares of Veeva ( VEEV ) were down more than 3% in recent Thursday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer Stocks Edge Higher Pre-Bell Wednesday
Sector Update: Consumer Stocks Edge Higher Pre-Bell Wednesday
Mar 10, 2026
09:13 AM EST, 12/17/2025 (MT Newswires) -- Consumer stocks were edging higher pre-bell Wednesday, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) advancing by 0.2% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) up 0.3%. Coursera ( COUR ) and Udemy ( UDMY ) said they have entered a definitive merger agreement under which...
Inspirato Announces Agreement to be Acquired by Exclusive Investments LLC
Inspirato Announces Agreement to be Acquired by Exclusive Investments LLC
Mar 10, 2026
DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated ( ISPO ) (“Inspirato”) , the premier luxury vacation club and property technology company, today announced that it has entered into a definitive agreement to be acquired by Exclusive Investments LLC (“Exclusive Investments”), the parent company of Exclusive Resorts. Under the terms of the agreement, Exclusive Investments will acquire all outstanding shares...
Nuvectis Pharma Starts Phase 1b Study With Osimertinib for Non-Small Cell Lung Cancer
Nuvectis Pharma Starts Phase 1b Study With Osimertinib for Non-Small Cell Lung Cancer
Mar 10, 2026
08:18 AM EST, 12/17/2025 (MT Newswires) -- Nuvectis Pharma ( NVCT ) said Wednesday it has started a phase 1b study testing NXP900 in combination with osimertinib in patients with non-small cell lung cancer. The new treatment is an oral drug candidate that stops or limits the SRX and YES1 enzymes, and the company is starting its first combination study...
UWM to Acquire Two Harbors in $1.3 Billion All-Stock Deal
UWM to Acquire Two Harbors in $1.3 Billion All-Stock Deal
Mar 10, 2026
09:13 AM EST, 12/17/2025 (MT Newswires) -- UWM (UWMC) will acquire Two Harbors Investment ( TWO/PA ) in an all-stock merger deal for an equity value of $1.3 billion, the companies said Wednesday. The companies said the deal is based on a fixed exchange ratio of 2.3328 shares of UWM class A common stock for each share of Two Harbors....
Copyright 2023-2026 - www.financetom.com All Rights Reserved